Derma Sciences Inc  

(Public, NASDAQ:DSCI)   Watch this stock  
Find more results for DSCI
4.93
+0.23 (4.89%)
Sep 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.69 - 4.96
52 week 2.85 - 6.29
Open 4.73
Vol / Avg. 0.00/49,891.00
Mkt cap 146.38M
P/E     -
Div/yield     -
EPS -0.34
Shares 28.31M
Beta 0.88
Inst. own 63%
Nov 7, 2016
Q3 2016 Derma Sciences Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Sep 27, 2016
Derma Sciences Inc at Ladenburg Thalmann Healthcare Conference - 8:30AM EDT - Add to calendar
Aug 10, 2016
Derma Sciences Inc at Canaccord Genuity Growth Conference
Aug 9, 2016
Q2 2016 Derma Sciences Inc Earnings Call
Aug 9, 2016
Q2 2016 Derma Sciences Inc Earnings Release
Jul 28, 2016
Derma Sciences Inc Conference Call to Discuss its Definitive Agreement to Acquire BioD, LLC and Sale of its First Aid Division
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 8.93% -24.11%
Operating margin -9.12% -26.00%
EBITD margin - -18.46%
Return on average assets 6.97% -16.03%
Return on average equity 7.88% -18.19%
Employees 260 -
CDP Score - -

Address

214 Carnegie Ctr Ste 300
PRINCETON, NJ 08540-6237
United States - Map
+1-609-5144744 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Officers and directors

Stephen T. Wills CPA Interim Executive Chairman of the Board, Principal Executive Officer
Age: 58
Bio & Compensation  - Reuters
John E. Yetter CPA Chief Financial Officer, Executive Vice President - Finance
Age: 62
Bio & Compensation  - Reuters
Robert C. Cole Group President - Traditional Wound Care and Corporate Accounts
Age: 62
Bio & Compensation  - Reuters
Frederic Eigner Executive Vice President - Operations; General Manager of Derma Sciences Canada, Inc.
Age: 65
Bio & Compensation  - Reuters
Bruce F. Wesson Vice Independent Lead Director
Age: 72
Bio & Compensation  - Reuters
Brett Donald Hewlett Director
Age: 52
Bio & Compensation  - Reuters
Srini Conjeevaram Independent Director
Age: 56
Bio & Compensation  - Reuters
Robert G. Moussa Independent Director
Age: 67
Bio & Compensation  - Reuters
Amy S. Paul Independent Director
Age: 64
Bio & Compensation  - Reuters